NCT02734433 2022-04-25
Study of Pexidartinib in Asian Subjects With Advanced Solid Tumors
Daiichi Sankyo
Phase 1 Completed
Clinical Trials
6 trialsNCT01004861 2022-01-04
Safety Study of PLX108-01 in Patients With Solid Tumors
Daiichi Sankyo
Phase 1 Completed
NCT02777710 2021-09-05
MEDIPLEX
Centre Leon Berard
Phase 1 Completed
NCT03291288 2021-05-14
Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)
Daiichi Sankyo
Phase 1 Completed
NCT03158103 2021-04-30
A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST)
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT02472275 2020-10-06
PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer
Barbara Ann Karmanos Cancer Institute
Phase 1 Completed